Location History:
- Gimhae-si, KR (2022)
- Daegu, KR (2023 - 2024)
Company Filing History:
6 out of 337 
1 out of 1,115 
Years Active: 2022-2025
Title: Innovations of Ju Youn Lee in Neurodegenerative Disease Research
Introduction
Ju Youn Lee is a prominent inventor based in Gimhae-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of neurodegenerative diseases. With a total of six patents to his name, his work focuses on innovative compositions that address critical health challenges.
Latest Patents
One of Ju Youn Lee's latest patents is a pharmaceutical composition for preventing or treating neurodegenerative diseases, which comprises a COX2 acetylating agent as an active ingredient. This invention is particularly noteworthy as it aims to inhibit the deposition of amyloid-β in brain neurons, reduce excessive neuroinflammatory responses, and enhance the phagocytosis of amyloid-β in microglial cells. The composition promotes COX2 acetylation in neurons and secretes specialized pro-resolving mediators (SPMs), making it a promising candidate for developing preventive or therapeutic agents for neurodegenerative diseases. Another significant patent involves a composition for diagnosing diseases associated with COX2 overexpression, which includes a compound that exhibits strong binding activity to a COX2 protein, along with a screening method for such diseases.
Career Highlights
Ju Youn Lee has worked with notable institutions, including the Kyungpook National University Industry-Academic Cooperation Foundation and the Industry-University Cooperation Foundation at Hanyang University. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
He has collaborated with esteemed colleagues, including Hee Kyung Jin and Jae-Sung Bae, which has further enriched his research endeavors and innovations.
Conclusion
Ju Youn Lee's innovative work in the field of neurodegenerative diseases showcases his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and a dedication to improving health outcomes.